William Koster

William Koster Email and Phone Number

Director (Chairman) At Ocuterra Therapeutics (Formerly Scifluor Life Sciences) @ eXIthera Pharmaceuticals Inc.
westborough, massachusetts, united states

William Koster's Contact Details

William Koster personal email

n/a

William Koster's Current Company Details

Exithera Pharmaceuticals Inc.

Director (Chairman) At Ocuterra Therapeutics (Formerly Scifluor Life Sciences)
westborough, massachusetts, united states
Employees:
6

William Koster Work Experience Details

  • Director (Chairman 2020-2021; Vice-Chairman 2021-Present)
    Ocuterra Therapeutics (Previously Named Scifluor Life Sciences) Apr 2020 - Present
    Greater Boston
  • Director (Chairman)
    Greater Boston Area
  • President And Ceo
    Northern Pilot Company, Llc Dec 2008 - Present
    Greater Boston Area
    Northern Pilot Company, LLC is a private consulting company providing strategic guidance to the pharmaceutical industry. The firm specializes in developing and optimizing business and R&D strategies and practices, portfolio management, evaluation of R&D assets, licensing and M&A, activities.
  • Director (Chairman)
    Scifluor Life Sciences, Llc (Renamed Ocuterra Therapeutics) Mar 2015 - Aug 2020
    Cambridge, Ma
  • Director
    Cadent Therapeutics (Luc And Ataxion Merger) Dec 2017 - Sep 2018
    Cambridge, Ma
  • Director (Chairman 2013-2016)
    Vedantra Pharmaceuticals Inc. (Renamed Elicio Therapeutics) Dec 2013 - Sep 2018
    Cambridge, Ma
  • Director
    Luc Therapeutics Inc. (Previously Named Mnemosyne) Jul 2013 - Mar 2017
    Cambridge, Ma
  • President And Ceo
    Neurogen Corporation Sep 2001 - Feb 2008
    Neurogen (Nasdaq symbol: NRGN), a public company in the biotechnology sector (subsequently acquired by Ligand Pharmaceuticals, Inc.) focused on creating small molecule drugs and spanning the R&D continuum from screen development, lead identification, lead optimization, preclinical development, through clinical proof-of-concept and up to Phase 3. R&D programs targeted four therapeutic areas: neuroscience, pain, inflammation, and diabetes/obesity. The clinical development portfolio consisted of two alpha-3 preferring, partial GABA agonists (adipiplon (Phase 2) and NG2-83 (Phase 1) for insomnia, anxiety, and schizophrenia, a partial D2 agonist (aplindore) in-licensed from Wyeth for Parkinson’s Disease (Phase 2) and RLS (Phase 2), a MCH-1 antagonist for obesity/biabetes (Phase 1b) and a VR-1 antagonist (NGD-8243 (MK-2295)) out-licensed to Merck for treatment of pain (Phase 2)
  • Senior Vice-President
    Bristol-Myers Squibb Dec 1971 - Aug 2001
    Began career at The Squibb Institute in basic research and ultimately, as SVP of the BMS Pharmaceutical Research Institute, lead worldwide drug discovery, preclinical development, and exploratory clinical development operations through Phase 2a. As head of the Institute's R&D assessment and integration team, performed the due diligence and valuation of the R&D assets leading to the acquisition of the DuPont Pharmaceutical Company.

William Koster Education Details

  • Tufts University
    Chemistry
  • Colby College
    Chemistry

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.

Frequently Asked Questions about William Koster

What company does William Koster work for?

William Koster works for Exithera Pharmaceuticals Inc.

What is William Koster's role in his/her workplace?

William Koster's role in his/her workplace is Director (Chairman) At Ocuterra Therapeutics (Formerly Scifluor Life Sciences).

What is William Koster's email address?

William Koster's email address is wi****@****uor.com

What is William Koster's direct phone number?

William Koster's direct phone number is +161768*****

What schools did William Koster attend?

William Koster attended Tufts University, and Colby College .